ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.0
  1. ホーム
  2. /反応

Sodium Carbonate → HCID 178518595、化合物

HRID 2294929
ノート
印刷プレビュー

反応式

HRID 2294929 の反応式
[O:1]=[C:2]1[CH2:7][CH2:6][CH:5]([N:8]2[CH2:13][CH2:12][CH:11]([N:14]3[C:18]4[CH:19]=[CH:20][CH:21]=[CH:22][C:17]=4[NH:16][C:15]3=[O:23])[CH2:10][CH2:9]2)[CH2:4][CH2:3]1.[NH2:24][C:25]1[CH:26]=[N:27][CH:28]=[N:29][CH:30]=1.C(O[BH-](OC(=O)C)OC(=O)C)(=O)C.[Na+].C([O-])([O-])=O.[Na+].[Na+]>C(Cl)(Cl)Cl.C(O)(=O)C.ClCCCl>[NH4+:8].[OH-:1].[N:27]1[CH:26]=[C:25]([NH:24][C@H:2]2[CH2:7][CH2:6][C@H:5]([N:8]3[CH2:13][CH2:12][CH:11]([N:14]4[C:18]5[CH:19]=[CH:20][CH:21]=[CH:22][C:17]=5[NH:16][C:15]4=[O:23])[CH2:10][CH2:9]3)[CH2:4][CH2:3]2)[CH:30]=[N:29][CH:28]=1
参加物実験手順後処理出典と根拠反応ノート

参加物

9

反応物 4

HCID 10340Sodium CarbonateHCID 344373Pyrimidin-5-amineHCID 5049666Sodium triacetoxyborohydrideHCID 97968491,3-dihydro-1-{1-[4-oxocyclohex-1-yl]piperidin-4-yl}-2H-benzimidazol-2-one

生成物 2

HCID 14923Ammonium HydroxideHCID 178518595HCID 178518595、化合物収率 54.3%

試薬・触媒・溶媒 3

HCID 111,2-Dichloroethane溶媒HCID 176Acetic Acid溶媒HCID 6212Chloroform溶媒

実験手順

A mixture of 0.25 g of 1,3-dihydro-1-{1-[4-oxocyclohex-1-yl]piperidin-4-yl}-2H-benzimidazol-2-one, 0.25 g of 5-aminopyrimidine (H. Bredereck, F. Effenberger and E. H. Schweizer, Chem. Ber. 1962 95, 803-9), 2 mL of 1,2-dichloroethane, 0.5 mL of acetic acid and 0.35 g of sodium triacetoxyborohydride was stirred at room temperature for 48 h. The reaction mixture was poured into 200 mL chloroform and 20 mL saturated aqueous Na2CO3 and the layers separated. The aqueous layer was extracted with 2×25 mL of CHCl3 and the combined organic layers dried over MgSO4 and concentrated under reduced pressure. Preparative TLC on silica gel, eluting with 85:15:5 Et2O:MeOH:conc. NH4OH gave 85 mg of trans-1,3-dihydro-1-{1-[1-(5-pyrimidinylamino)cyclohex-4-yl]piperidin-4-yl}-2H-benzimidazol-2-one: 1H NMR (400 MHz, CDCl3 +5% CD3OD) 8.44 (s, 1H), 8.12 (m, 2H), 7.36 (m, 1H), 7.09 (m, 3H), 4.3 (br m, 1H), 3.65 (br m, 2H), 3.2 (br m, 2H), 2.45 (m, 5H), 2.0 (m, 2H), 1.85 (br m, 4H), 1.65 (m, 4H): Analysis calculated for C22H28N6 O.1.05 H2O.0.25 CHCl3 : C: 60.56, H: 7.17, N: 18.68; found C: 60.81, H: 7.17, N: 18.68, and 75 mg of cis-1,3-dihydro-1-{1-[1-(5-pyrimidinylamino)cyclohex-4-yl]piperidin-4-yl}-2H-benzimidazol-2-one: 1H NMR (400 MHz, CDCl3 +5% CD3OD) 8.43 (s, 1H), 8.08 (m, 2H), 7.65 (m, 1H), 7.1 (m, 3H), 4.6 (br m, 1H), 3.6 (br m, 2H), 3.25 (br m, 2H), 3.0 (br m, 5H), 2.3 (m, 4H), 2.0 (m, 2H), 1.75 (br m, 2H), 1.35 (m, 2H): Analysis calculated for C22H28 N6O.0.25 H2O.0.75 CHCl3 : C: 55.90, H: 5.97, N: 17.16; found C: 56.19, H: 5.96, N: 17.14.

後処理

  1. customthe layers separated
  2. extractionThe aqueous layer was extracted with 2×25 mL of CHCl3
  3. dry with materialthe combined organic layers dried over MgSO4
  4. concentrationconcentrated under reduced pressure
  5. washPreparative TLC on silica gel, eluting with 85:15:5 Et2O

出典と根拠

ORDレコード
ord-3efbe1d4c4d1490e850618c5423df07e
出典データセット
uspto-grants-1997_11
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US05691323

反応ノート

読み込み中…

このページの内容参加物実験手順後処理出典と根拠反応ノート